Market Overview

Teleflex Introduces Innovative Technology for Lung Isolation Procedures

Related TFX
Teleflex On Accelerating Top-Line Growth Trajectory; Upgrading To Outperform
Benzinga's Top Upgrades, Downgrades For September 8, 2017

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announced today its Rusch^® EZ-Blocker^™ Disposable Endobronchial Blocker has received 510(k) clearance. The addition of the EZ-Blocker Endobronchial Blocker to the Teleflex Airway Management portfolio enhances the company's product offerings, which include clinically differentiated Rusch and Sheridan^® brands of endotracheal and endobronchial products.

Posted-In: News FDA


Related Articles (TFX)

View Comments and Join the Discussion!

Partner Center